Hong Seng Consolidated Berhad 過去の業績

過去基準チェック /06

Hong Seng Consolidated Berhadは22.2%の年平均成長率で業績を伸ばしているが、Healthcare業界はgrowingで20.2%毎年増加している。売上は成長しており、年平均33.2%の割合である。

主要情報

22.2%

収益成長率

35.5%

EPS成長率

Healthcare 業界の成長	31.5%
収益成長率	33.2%
株主資本利益率	-21.9%
ネット・マージン	-409.6%
前回の決算情報	31 Mar 2024

Investors Shouldn't Be Too Comfortable With Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Robust Earnings

Nov 30

Recent updates

Hong Seng Consolidated Berhad (KLSE:HONGSENG) Has Debt But No Earnings; Should You Worry?

Sep 23

Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?

Jun 09

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) Weighed On By Its Debt Load?

Oct 12

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) A Risky Investment?

May 11

We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Can Stay On Top Of Its Debt

Jan 27

Here's Why We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Is Well Worth Watching

Jan 04

Investors Shouldn't Be Too Comfortable With Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Robust Earnings

Nov 30

Shareholders Would Enjoy A Repeat Of Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Recent Growth In Returns

Oct 26

Hong Seng Consolidated Berhad (KLSE:HONGSENG) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Aug 31

We Ran A Stock Scan For Earnings Growth And Hong Seng Consolidated Berhad (KLSE:HONGSENG) Passed With Ease

Aug 09

収支内訳

Hong Seng Consolidated Berhad の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

KLSE:HONGSENG 収益、費用、利益 ( )MYR Millions
日付	収益	収益	G+A経費
31 Mar 24	15	-61	14
30 Jun 23	9	-27	17
31 Mar 23	12	-3	19
31 Dec 22	126	49	23
30 Sep 22	198	97	25
30 Jun 22	257	135	24
31 Mar 22	258	118	21
31 Dec 21	196	82	17
30 Sep 21	146	44	12
31 Dec 20	27	-4	5
30 Sep 20	2	-7	5
30 Jun 20	3	-8	4
31 Mar 20	4	-7	5
31 Dec 19	5	-7	2
30 Sep 19	8	-13	4
30 Jun 19	10	-14	4
31 Mar 19	10	-13	6
31 Dec 18	16	-26	6
30 Sep 18	24	-20	6
30 Jun 18	26	-24	8
31 Mar 18	29	-27	9
31 Dec 17	27	-10	15
30 Sep 17	27	-12	14
30 Jun 17	29	-11	14
31 Mar 17	30	-8	12
31 Dec 16	31	-8	12
30 Sep 16	38	-3	14
30 Jun 16	39	1	13
31 Mar 16	42	2	14
31 Dec 15	42	4	14
30 Sep 15	39	-2	12
30 Jun 15	39	-5	15
31 Mar 15	38	-5	16
31 Dec 14	36	-9	18
30 Sep 14	33	-2	16
30 Jun 14	35	1	16
31 Mar 14	34	2	16

質の高い収益: HONGSENGは現在利益が出ていません。

利益率の向上: HONGSENGは現在利益が出ていません。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: HONGSENGは利益を出していないが、過去 5 年間で年間22.2%の割合で損失を削減してきた。

成長の加速: HONGSENGの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: HONGSENGは利益が出ていないため、過去 1 年間の収益成長をHealthcare業界 ( 3.9% ) と比較することは困難です。

株主資本利益率

高いROE: HONGSENGは現在利益が出ていないため、自己資本利益率 ( -21.92% ) はマイナスです。

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

企業分析と財務データの現状

データ	最終更新日（UTC時間）
企業分析	2025/02/16 06:42
終値	2025/02/14 00:00
収益	2024/03/31
年間収益	2024/03/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージ	データ	タイムフレーム	米国ソース例
会社財務	10年	損益計算書キャッシュ・フロー計算書貸借対照表	SECフォーム10-K SECフォーム10-Q
アナリストのコンセンサス予想	+プラス3年	予想財務アナリストの目標株価	アナリストリサーチレポート Blue Matrix
市場価格	30年	株価配当、分割、措置	ICEマーケットデータ SECフォームS-1
所有権	10年	トップ株主インサイダー取引	SECフォーム4 SECフォーム13D
マネジメント	10年	リーダーシップ・チーム取締役会	SECフォーム10-K SECフォームDEF 14A
主な進展	10年	会社からのお知らせ	SECフォーム8-K

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用^。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートの作成に使用した分析モデルの詳細は、Githubページでご覧いただけます。また、レポートの使用方法に関するガイドや、Youtubeでのチュートリアルもご用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Hong Seng Consolidated Berhad 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、。アナリストの投稿は一日中更新されます。3

アナリスト	機関
Terence Wong	CGS International
Shin Kao	OSK-DMG
Swee Tyng Chin	TA Securities Holdings Berhad

Hong Seng Consolidated Berhad 過去の業績

過去 基準チェック /06

主要情報

最近の業績更新

Third quarter 2023 earnings released: RM0.001 loss per share (vs RM0.004 profit in 3Q 2022)

Second quarter 2023 earnings released: RM0.002 loss per share (vs RM0.008 profit in 2Q 2022)

Full year 2022 earnings released: EPS: RM0.019 (vs RM0.016 in FY 2021)

Investors Shouldn't Be Too Comfortable With Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Robust Earnings

Full year 2022 earnings released: EPS: RM0.019 (vs RM0.013 in FY 2021)

Hong Seng Consolidated Berhad Reports Impairment Charges for the Fourth Quarter Ended September 30, 2022

Recent updates

New minor risk - Financial data availability

New major risk - Market cap size

Hong Seng Consolidated Berhad Announces the Resignation of Christopher Chan Hooi Guan as Executive Director

High number of new directors

Hong Seng Consolidated Berhad (KLSE:HONGSENG) Has Debt But No Earnings; Should You Worry?

Less than half of directors are independent

Hong Seng Consolidated Berhad Appoints Yacob Bin Mustafa as Independent and Non Executive Chairman

Hong Seng Consolidated Berhad, Annual General Meeting, Aug 29, 2024

Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?

Less than half of directors are independent

New minor risk - Financial data availability

Hong Seng Consolidated Berhad Announces the Resignation of Loo Hui Yan as Joint Secretary

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) Weighed On By Its Debt Load?

Third quarter 2023 earnings released: RM0.001 loss per share (vs RM0.004 profit in 3Q 2022)

New major risk - Share price stability

Hong Seng Consolidated Berhad Announces Cessation of Teoh Soon Han as Alternate Director

Second quarter 2023 earnings released: RM0.002 loss per share (vs RM0.008 profit in 2Q 2022)

Hong Seng Consolidated Berhad Appoints Loo Hui Yan as Joint Secretary

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) A Risky Investment?

Hong Seng Consolidated Berhad entered into a Shares Sale Agreement to acquire Alliance EV Sdn Bhd from CSH Alliance Berhad for MYR 20 million.

Full year 2022 earnings released: EPS: RM0.019 (vs RM0.016 in FY 2021)

Hong Seng Consolidated Berhad agreed to acquire 51% stake in Innov8tif Holdings Sdn Bhd from Innov8tif Consortium Sdn Bhd for MYR 30.9 million.

Hong Seng Consolidated Berhad, Annual General Meeting, Feb 27, 2023

We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Can Stay On Top Of Its Debt

Here's Why We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Is Well Worth Watching

Investors Shouldn't Be Too Comfortable With Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Robust Earnings

Full year 2022 earnings released: EPS: RM0.019 (vs RM0.013 in FY 2021)

Hong Seng Consolidated Berhad Reports Impairment Charges for the Fourth Quarter Ended September 30, 2022

High number of new and inexperienced directors

Shareholders Would Enjoy A Repeat Of Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Recent Growth In Returns

Hong Seng Consolidated Berhad Appoints Tea Sor Hua as Company Secretary, Effective October 1, 2022

Hong Seng Consolidated Berhad Announces Re-Designation of Tuan Ng Keok Chai from Member of Remuneration Committee to Chairman of Remuneration Committee

Hong Seng Consolidated Berhad Appoints Dato Kang Chez Chiang as Independent and Non Executive Member of Nomination Committee

Hong Seng Consolidated Berhad (KLSE:HONGSENG) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Hong Seng Consolidated Berhad Reports Plant and Equipment Written Off for the Quarter Ended June 30, 2022

Third quarter 2022 earnings released: EPS: RM0.004 (vs RM0.013 in 3Q 2021)

We Ran A Stock Scan For Earnings Growth And Hong Seng Consolidated Berhad (KLSE:HONGSENG) Passed With Ease

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorated over the past week

High number of new and inexperienced directors

Investor sentiment deteriorated over the past week

Full year 2021 earnings: EPS and revenues miss analyst expectations

Hong Seng Consolidated Berhad Appoints Dato Mohamed Suffian Bin Awang as Independent and Non Executive Chairman

Hong Seng Consolidated Berhad, Annual General Meeting, Feb 25, 2022

Second quarter 2022 earnings: Revenues miss analyst expectations

Robust Potential Sdn Bhd entered into an agreement to acquire Hong Seng Priority Management Sdn Bhd from Hong Seng Consolidated Berhad (KLSE:HONGSENG) for MYR 34.5 million.

Senior Independent Non-Executive Director Mun Wong has left the company

Full year 2021 earnings released: EPS RM0.022 (vs RM0.025 loss in FY 2020)

Hong Seng Consolidated Berhad Announces Appointment of Mr. Christopher Chan Hooi Guan as Executive Director

Independent Non Executive Director has left the company

Hong Seng Consolidated Berhad Resigns Ym Tengku Farith Rithauddeen as Independent and Non Executive Independent Director

Hong Seng Consolidated Berhad Resigns Tengku Farith Rithauddeen as Independent and Non Executive Chairman of Nomination Committee

Third quarter 2021 earnings released: EPS RM0.006 (vs RM0.002 loss in 3Q 2020)

Hong Seng Consolidated Berhad Announces Resignation of Mr. Lim Peng Tong as Executive Director

New 90-day high: RM1.35

New 90-day high: RM1.15

Second quarter 2021 earnings released: EPS RM0.003

New 90-day low: RM0.99

Hong Seng Consolidated Berhad (KLSE:HONGSENG) entered into a share sale agreement to acquire remaining 49% stake in HS Bio Supplies Sdn Bhd from United ICT Consortium Sdn. Bhd. For MYR 0.98 million.

MSCM Holdings Berhad Announces Cessation of Wong Yee Ming as Non-Independent and Non-Executive Alternate Director

First quarter earnings released

New 90-day high - RM1.50

Landasan Simfoni Sdn Bhd entered into a share sale agreement to acquire 47.19% sake in MSCM Holdings Berhad (KLSE:MYSCM) from MMag Holdings Berhad (KLSE:MMAG) for MYR 0.75 million.

New 90-day high - RM0.20

収支内訳

収益と収入の歴史

フリー・キャッシュフローと収益の比較

過去の収益成長分析

株主資本利益率

過去基準チェック /06